GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » APT Medical Inc (SHSE:688617) » Definitions » Net-Net Working Capital

APT Medical (SHSE:688617) Net-Net Working Capital : ¥13.15 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is APT Medical Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

APT Medical's Net-Net Working Capital for the quarter that ended in Mar. 2024 was ¥13.15.

The industry rank for APT Medical's Net-Net Working Capital or its related term are showing as below:

SHSE:688617's Price-to-Net-Net-Working-Capital is ranked worse than
89.51% of 448 companies
in the Medical Devices & Instruments industry
Industry Median: 6.175 vs SHSE:688617: 34.52

APT Medical Net-Net Working Capital Historical Data

The historical data trend for APT Medical's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

APT Medical Net-Net Working Capital Chart

APT Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net-Net Working Capital
Get a 7-Day Free Trial -0.62 1.79 17.18 13.11 12.95

APT Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.38 9.92 11.52 12.95 13.15

Competitive Comparison of APT Medical's Net-Net Working Capital

For the Medical Devices subindustry, APT Medical's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


APT Medical's Price-to-Net-Net-Working-Capital Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, APT Medical's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where APT Medical's Price-to-Net-Net-Working-Capital falls into.



APT Medical Net-Net Working Capital Calculation

APT Medical's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net-Net Working Capital(A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1336.391+0.75 * 41.416+0.5 * 327.953-610.981
-0-54.859)/66.8614
=12.95

APT Medical's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2024 is calculated as

Net-Net Working Capital(Q: Mar. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1229.875+0.75 * 42.419+0.5 * 349.66-504.895
-0-52.596)/66.8614
=13.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


APT Medical  (SHSE:688617) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


APT Medical Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of APT Medical's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


APT Medical (SHSE:688617) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, Songpingshan Langshan Road, Xili Street, Room 601, Building B, Tongfang Information Port, Songpingshan Community, Nanshan District, Guangdong Province, Shenzhen, CHN, 518000
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
Executives
Dai Zhen Hua Directors, senior managers
Cheng Zheng Hui Directors, senior managers
Zhang Yong Core technical personnel
Liu Fang Yuan senior management
Wang Wei senior management
Senior management, core technical personnel
Xu Yi Qing Directors, senior managers
Han Yong Gui Senior management, core technical personnel

APT Medical (SHSE:688617) Headlines

No Headlines